Elderly men comprise a large percentage of men diagnosed with prostate cancer (PrCa). Although localized PrCa is often indolent, older men tend to be diagnosed with higher-stage disease and are more likely to die from PrCa than younger men. Multiple factors other than age play an important ...
Viewpoint November 11, 2024 Threats to Women’s Health in Prisons and Jails JAMA Internal Medicine Viewpoint November 11, 2024 Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era JAMA Internal Medicine Original Investigation November 11, 2024JAMA...
Representing 18% of male cancers, carcinoma of the prostate gland is the second most common cancer and the third leading cause of cancer deaths in US males. In 1982, it is estimated 73,000 new cases and 23,000 deaths will occur from the most common cancer in men older than 65 years of...
As a result of increasing life expectancy, the cancer incidence in older population is on the rise. Ovarian cancer (OC) is predominantly the disease of elderly women. More than half of all OC occur in women older than 65 years. The incidence of the disease increases with the advancing age...
About 75% of prostate cancers are diagnosed in men older than 65 years,4 while being rarely diagnosed in men under 40 years of age.5 African American men have the highest incidence and death rate from PCa in the United States. Though genetic factors have been implicated, the men who are ...
Objective: In the context of increasing prostate cancer survivorship, evidence of unmet supportive care needs and growing economic health-care restraints, this review examined and evaluated best approaches for developing self-management programmes to meet men's survivorship needs.Methods: A search of int...
13 Background: The aim of this study is to evaluate the practice pattern of management of NCCN low-risk prostate cancer (LRPC) in a population-based cohort of Australian men. Methods: This is prospective cohort of men captured in Prostate Cancer Outcomes Registry Victoria (PCOR-Vic), who wer...
Conservative management of low‐risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database Background Management for men aged ≤55?years with low‐risk prostate cancer (LRPC) is debated given quality‐of‐life implications with definit...
Objective To perform a systematic review of data guiding the assessment of elderly prostate cancer patients that addresses the risk from cancer and treatment, and to discuss a patient-centered approach to incorporating these factors into decision making. Evidence acquisition Evidence was gathered via a...
2022, Archives of Osteoporosis Regulation and role of CAMKK2 in prostate cancer 2022, Nature Reviews Urology Management of osteoporosis in older men 2021, Aging Clinical and Experimental Research View all citing articles on Scopus 1 Joint first author. ...